Advisory Services Network’s Regenxbio RGNX Stock Holding History

Advisory Services Network’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.66K	Buy	+556	New	+$5.84K	﹤0.01%	3889
2025 Q4	–	Sell	-200	Closed	-$1.93K	–	3731
2025 Q3	$1.93K	Buy	+200	New	+$1.77K	﹤0.01%	3808
2020 Q4	–	Sell	-13	Closed	-$454	–	3635
2020 Q3	$0	Buy	+13	New	+$424	﹤0.01%	3627

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's RGNX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Regenxbio (RGNX) in Q1 2026: 556 shares worth $4.66K. The stake represents ﹤0.01% of the portfolio and ranks #3889 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in RGNX as recently as Q3 2025.

Advisory Services Network first reported a position in RGNX in Q3 2020 and has held it in 3 quarters since. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

Advisory Services Network held 556 shares of Regenxbio worth $4.66K as of Q1 2026.
Regenxbio was a new Advisory Services Network position in Q1 2026.
Regenxbio made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3889 holding.
Advisory Services Network first reported a position in Regenxbio in Q3 2020 and has held it in 3 quarters since.
178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.